European drug discovery platform emerges in €196M effort

Europe's pharma community is revving up a drug discovery engine. A new effort involving 30 partners--including Bayer, Johnson & Johnson's ($JNJ) Janssen and 5 other large pharmas--has launched to spark discovery of new treatments, using a crowdsourcing and open-innovation approach. Don't expect them to pull off the effort without software support. One of the 30 project partners is ChemAxon, a Budapest, Hungary-based provider of chemical informatics and desktop software. Article